Capecitabine (brand name: Xeloda®) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. It is enzymatically converted to fluorouracil in the body, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is FDA-approved for:
More on [ Capecitabine ]

Capecitabine ( Xeloda ) - Manufacturer's information on this oral cancer therapy that can be used for the treatment of breast cancer and colorectal cancer.
Meta Description: [ Your extensive online resource for information on the oral chemotherapy Xeloda (capecitabine). Access the latest news, trial data and product literature. ]
Capecitabine (Xeloda) - Consumer information sheet provided by the U.S. Food and Drug Administration Center for Drug Evaluation and Research.
Meta Description: [ Consumer Information Page ]
DrugDigest: Capecitabine ( Xeloda ) - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
Xeloda - Features product details for US consumers and healthcare professionals as well as information about breast and colorectal cancer. [Requires Flash]
Meta Description: [ XELODA.com provides information and resources on breast cancer, colorectal cancer and XELODA, the first FDA-approved oral chemotherapy for metastatic Breast and Colorectal Cancer. ]